CN Patent

CN103382174A — 作为组胺h3受体调节物的环丙胺衍生物

Assigned to Abbott Laboratories · Expires 2013-11-06 · 13y expired

What this patent protects

下式(I)的化合物 可用于治疗由组胺-3受体配体预防或改善的病症或障碍。还公开了含有所述组胺-3受体配体的药物组合物、使用这样的化合物和组合物的方法以及用于制备式(I)范围内的化合物的方法。

USPTO Abstract

下式(I)的化合物 可用于治疗由组胺-3受体配体预防或改善的病症或障碍。还公开了含有所述组胺-3受体配体的药物组合物、使用这样的化合物和组合物的方法以及用于制备式(I)范围内的化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103382174A
Jurisdiction
CN
Classification
—
Expires
2013-11-06
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.